Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.11B
Enterprise Value2.25B
P/E Ratio171.24
PEG Ratio-2.47
Price/Sales Ratio11.29
Price/Book Ratio30.69
Enterprise/Revenue11.86
Enterprise/EBITDA53.25

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.19

Income Statement

Revenue210.66M
Revenue/Share1.7
Gross Profit82.33M
EBITDA51.08M
Net Income17.62M
Diluted EPS0.14

Balance Sheet

Total Cash70.11M
Total Cash/Share0.58
Total Debt189.76M
Total Debt/Equity2.49
Current Ratio0.84
Book Value Per Share0.81

Price History

52-Week Change1.26
52-Week High24.25
52-Week Low15.7
Moving Average 50 Days21.82
Moving Average 200 Days20.17

Statistics

Average Volume3.81M
Shares Outstanding121.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.36
Last Split Factor10177:10000
Last Split DateMay 04, 2009
AD